C-4′ Truncated carbocyclic formycin derivatives

Tetrahedron

Volumn 62, Issue 29, 2006, Pages 7009-7013

  Zhou, Jian ^a   Yang, Minmin ^a   Akdag, Akin ^a   Schneller, Stewart W ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Antiviral testing; Carbocyclic C nucleosides; Epoxide ring opening; Formycin

Indexed keywords

(1ALPHA,2ALPHA,3BETA) 1,2 DIHYDROXY 3 (7 AMINO 1H PYRAZOLO[4,3 D]PYRIMID 3 YL)CYCLOPENTANE; (1ALPHA,2ALPHA,3BETA) 1,2 DIHYDROXY 3 (7 HYDROXY 1H PYRAZOLO[4,3 D]PYRIMID 3 YL)CYCLOPENTANE; FORMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RACEMIZATION; STRUCTURE ACTIVITY RELATION;

EID: 33744920852     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2006.04.068     Document Type: Article

References (28)

1. Schneller S.W. Curr. Top. Med. Chem. 2 (2002) 1087-1092
2. Herdewijn P., Balzarini J., De Clercq E., and Vanderhaeghe H. J. Med. Chem. 28 (1985) 1385-1386
3. De Clercq E. Biochem. Pharmacol. 36 (1987) 2567-2575
4. Cools M., and De Clercq E. Biochem. Pharmacol. 38 (1989) 1061-1067
5. Hori M., Ito E., Takita T., Koyama G., Takeuchi T., and Umezawa H. J. Antibiot. 17A (1964) 96-99
6. Koyama G., and Umezawa H. J. Antibiot. 18A (1965) 175-177
7. For a leading reference see. Evans G.B., Furneaux R.H., Gainsford G.J., Hanson J.C., Kicska G.A., Sauve A.A., Schramm V.L., and Tyler P.C. J. Med. Chem. 46 (2003) 155-160
8. Wolfe M.S., Lee Y.H., Bartlett W.J., Borcherding D.R., and Borchardt R.T. J. Med. Chem. 35 (1992) 1782-1791
9. Hasobe M., Liang H., Ault-Riche D.B., Borcherding D.R., Wolfe M.S., and Borchardt R.T. Antiviral Chem. Chemother. 4 (1993) 245-248
10. De Clercq E., and Neyts J. Rev. Med. Virol. 14 (2004) 289-300
11. 3e
12. Assay method described in. Roy A., Schneller S.W., Keith K.A., Hartline C.B., and Kern E.R. Bioorg. Med. Chem. 13 (2005) 4443-4449
13. Chun B.K., Song G.Y., and Chu C.K. J. Org. Chem. 66 (2001) 4852-4853
14. Boyer S.J., and Leahy J.W. J. Org. Chem. 62 (1997) 3976-3980
15. Zhou J., Yang M., and Schneller S.W. Tetrahedron Lett. 45 (2004) 8233-8234
16. Crotti P., Di Bussolo V., Favero L., Macchia F., and Pineschi M. Eur. J. Org. Chem. 8 (1998) 1675-1686
17. Evans P.A., Cui J., Gharpure S.J., Polosukhin A., and Zhang H.-R. J. Am. Chem. Soc. 125 (2003) 14702-14703
18. Kita Y., Futamura J., Ohba Y., Sawama Y., Ganesh J.K., and Fujioka H. J. Org. Chem. 68 (2003) 5917-5924
19. Rycroft A.D., Singh G., and Wightman R.H. J. Chem. Soc., Perkin Trans. 1 (1995) 2667-2668
20. Buchanan J.G., Quijano M.L., and Wightman R.H. J. Chem. Soc., Perkin Trans. 1 (1992) 1573-1576
21. Buchanan J.G., Jumaah A.O., Kerr G., Talekar R.R., and Wightman R.H. J. Chem. Soc., Perkin Trans. 1 (1991) 1077-1083
22. Buchanan J.G., Stobie A., and Wightman R.H. Can. J. Chem. 58 (1980) 2624-2627
23. Viruses subjected (±)-4 were influenza A (H1N1 and H3N2), influenza B, respiratory syncytial virus, herpes simplex virus 1 and 2, human cytomegalovirus, varicella zoster virus, vaccinia virus, cowpox virus, adenovirus type 1, Punta Toro virus, rhinovirus type 2, Venezuelan equine encephalitis, yellow fever, Pichinde, HIV-1 and HIV-2, Dengue virus, measles, parainfluenza-3, reovirus, Sindbis virus, Coxsackie virus B4, and vesicular stomatitis.
24. For leading references on the procedures used for the assays see
25. Rajappan V.P., Schneller S.W., Williams S.L., and Kern E.R. Bioorg. Med. Chem. 10 (2002) 883-886
26. Siddiqi S.M., Chen X., Schneller S.W., Ikeda S., Snoeck R., Andrei G., Balzarini J., and De Clercq E. J. Med. Chem. 37 (1994) 551-554
27. (April 11, 2006). http://www.usu.edu/iar/Brochure/brochure.html
28. To simplify viewing the ORTEP representation in Figure 2 the hydrogen atoms are omitted. However, the hydrogen atom on C(6) is oriented down while hydrogens on C(9) and C(10) are up.